First patient enrolled in BrainQ's Pivotal Trial, EMAGINE™, for frequency-tuned electromagnetic field therapy to reduce disability following Ischemic Stroke
On December 09, 2021, BrainQ announced the enrollment of the first patient at MedStar National Rehabilitation Hospital in its pivotal, randomized, double-blind, multicenter trial, EMAGINE (the BQ5 Study). The trial is piloted on moderate to severe ischemic stroke patients to recover and evaluate its frequency-tuned electromagnetic field treatment.
Dr. Jeffrey Saver, director of the UCLA Comprehensive Stroke and Vascular Neurology Program and a co-lead Principal Investigator for BrainQ's pivotal tria...
